2010 Event Archives

Holiday Season Kickoff- Pub Night

The Fireside Room at the seasonally apropos Arctic Club Hotel served as the gathering place for the networking night of the holiday season!  Eighty-five of your closest life sciences colleagues warmed themselves by the fire (and with holiday libations!) while reminiscing on the events and successes of 2010 and toasting bright and bold future of 2011!  

Return to top

The Pathway to Biosimilars?

CMC Icos in Bothell was host to more than fifty life science professionals on Thursday, November 18, 2010 for WBBA's program "The Pathway to Biosimilars?" 

Biosimilars, as the name implies, are drugs that are similar to, but not the same as innovator biologics. Biotechnology based therapies that fight diseases such as cancer, diabetes, and Alzheimer’s and other diseases are made from living cells — a process far more complex than the one used to manufacture chemical-based drugs such as aspirin. 

The biologics market is currently worth about $40 billion and is growing at over 20% per year. It is expected to represent 50% of new product approvals by 2015 and 70% by 2025 (source: Kalorama). The Healthcare Reform bill passed by the House of Representatives in March 2010 includes an historic provision which creates a pathway to enable the FDA to approve biosimilars. This new scenario provides opportunities for companies developing biosimilars as well as a challenge to biologics innovators who will face new competition.

The panelists:

Thank you everyone that attended!

This program would not have been possible without the support of our sponsors CMC Icos, Fenwick & West and We Work for Health.  Thank you! 

Return to top

Innovative Investing in Global Health: What’s in it for your organization? - Domesticating Global Health Part 4

On Wednesday, November 3, more than 50 attendees discussed recent developments on the strategies used to advance Washington’s Global Health initiatives and find keys to success for product development in emerging markets.  This was the fourth and final in a series of Domesticating Global Health programs presented by WBBA in 2010.  The key takeaway: global is also local – and innovation in our state is not only translating to lives saved worldwide but also can mean potential for business development.

Questions addressed were:

- How does Global Health benefit Washington’s Life Science community and the state’s economy?
- What creative global health financing mechanisms are available to continue to partner and further leverage our innovation economy?

Also discussed was the recently passed global health competitiveness bill and creation of  the Global Health Technologies Competitive Program Board designed to create a funding mechanism and a grant program to ensure that Washington remains competitive in global health innovation and to ensure that the development, manufacture, and delivery of global health products will become an even more dynamic part of the state's economy.

Program Panelists:

  • Melinda Moree, CEO, BIO Ventures for Global Health (BVGH)- Moderator
  • Scott Jackson, VP for External Relations, PATH
  • Representative Phyllis Gutiérrez Kenney, 46th District  Presentation Slides
  • John G. Abbott, Director, Standards & Regulations at Philips Healthcare  Presentation Slides

Thank you to our sponsors, partner and host:

BNBuilders; City of Seattle- Office of Economic Development; Fenwick & West; Washington Global Health Alliance; Seattle BioMed

Return to top

Governor's Life Sciences Summit and Annual Meeting 2010

The Washington Biotechnology & Biomedical Association (WBBA) combined the power of both the Governor’s Life Sciences Summit and its Annual Meeting. More than 700 leaders of Washington’s life sciences community attended on Friday, October 22, 2010. The intense four-hour program focused on a celebration of the recent successes of Washington state life sciences organizations, and featured an in-depth discussion of the industry’s current challenges and coming opportunities locally, nationally and globally.
Special thanks to our most valued sponsors
View the photo album from the event

“This summit celebrates the importance of the life sciences industry to our state’s economic future,” said WBBA president Chris Rivera. “Life sciences continues to be one of Washington’s fastest growing jobs sectors, in spite of a challenging economy and is absolutely critical to our state and the innovation economy of today and tomorrow.”
Read the entire pre-event press release October 21, 2010
Read the post event summary
WBBA released their 2010 Annual Report

It's not too late to participate! For the first time, WBBA, in partnership with Global Health Nexus, Seattle webcasted this event.
Watch webcast
View program slides - Rivera   View program slides - Feldbaum  View program slides - Alyward

Return to top

Planning for Your Drug Development Success: From the Bench to the Clinic

On Tuesday, September 14, more than 60 WBBA members gathered at Institute for Systems Biology to gather information and tools to help them on the road to drug development.  The discovery and identification of a new molecular entity (NME) and the application of research required to show a proof-of-principle for a therapeutic agent can be rife with pitfalls and it is extremely difficult to qualify a new prospect for venture funding.  The presentation took the audience from early discovery, the demonstration of efficacy, drug/biologic agent exposure, early candidate selection, and the preclinical safety aspects which are often missed by startups. Also discussed were scale-up and impurity issue considerations for the Active Pharmaceutical Ingredient (API) during the development phases through late stage drug/biologic development, selection of a preclinical safety evaluation partner, API supply, and regulatory filings.

The program was led by moderator: Stephen Frantz, PhD, DABT, Senior Director of Business Development, Pacific Northwest, MPI Research, Inc. Presentation Slides and the panelists included:
David Brewster, PhD, Vice President & Senior Safety Expert for Global Non-Clinical Safety, F. Hoffman-La Roche Presentation Slides
Jerry Moore, MS, Co-Founder & Vice President, Pharmacology & Pharmacokinetics, Pacific BioDevelopment Presentation Slides
Roger Ulrich, PhD, Chief Development Officer, Calistoga Pharmaceuticals Presentation Slides
Richard "Ric" Slauter, PhD, DABT, Senior Director of Drug Metabolism & Pharmacokinetics, MPI Research, Inc. Presentation Slides coming soon.

Thank you to our sponsors: Cambridge Major Laboratories, Inc.; Kineta; MPI Research; UW Professional and Continuing Education; Xcelience; and our venue host Institute for Systems Biology.

Return to top

WBBA's Sixth Annual Golf Invitational

Think Masters, US Open, British Open, PGA Championship - the holy grail of golf!  WBBA's Sixth Annual Golf Invitational, the only funding event of 2010 directly benefiting the industry's political action committee - the WBBA BIOPAC, was held September 13 at the private Fairwood Golf & Country Club in Renton.

Over 100 golfers enjoyed a perfect September day on the course.  Congratulations to the winning foursome of Ron Castagno, Chad Hedlee, Tony Kanaly and Bart Maple!  Additional prizes were given to golfers with the longest drive, closest to the pin and the highest score!  A silent auction was held to raise additional funds for the Biopac.  Thank you to all of our item donors and purchasers. Don't miss the fun and fantastic golf next year!

Thank you to the Golf Committee and Co-chairs, Tony Ford and Jason Berger for their dedication to this event. 

The tournament would not be possible without our sponsors and we would like to thank our premier sponsor:and the other generous sponsors for their continued committment: Luncheon sponsor - Biomed Realty Trust; Photo sponsor - Seed IP Law Group PLLC; Golf Cart sponsor - Skanska; Beverage Cart sponsor - BNBuilders; 150-Yard Sign sponsor - Pacific Biomarkers, Inc.; and Skilled Hole sponsor - Wells Fargo Insurance Services.

Return to top

Healthcare IT

The Washington Biotechnology & Biomedical Association (WBBA) was proud to present Healthcare IT (HIT) on Wednesday, August 25, 2010.  HIT provides for the comprehensive management of health information and its secure exchange between consumers, providers, government and quality entities, and insurers. HIT is a promising tool for improving the overall quality, safety and efficiency of the health delivery system. The Administration has invested $19 billion from the economic stimulus program to support electronic medical records, yet most healthcare providers, let alone consumers, are still struggling to adopt technologies that promise to deliver on a new era of more efficient, personalized healthcare.

WBBA brought together some of the region's experts in software and emerging technologies who are driving HIT innovations to create more effective new medicines, help consumers take better control of their wellness, and enable providers to deliver healthcare more efficiently.

The dynamic and interactive panel discussion, highlighted how IT is changing healthcare, and what hurdles still exist before the era of personalized medicine and care can be realized. Discussion included ways in which HIT can make a meaningful contribution to healthcare quality.

Our panel was led by moderator Eric Schadt, Ph.D, Chief Scientific Officer, at Pacific Biosciences.  Panelists included:
Jac Davies, Director, Beacon Community of the Inland Northwest, Inland Northwest Health Services Presentation Slides
Stephen H. Friend MD PhD, President and Co-Founder, Sage Bionetworks
Rod Hochman, Chief Executive Officer, Swedish Medical Center Presentation Slides
Jim Karkanias, Partner and Senior Director of Applied Research and Technology, Microsoft Corporation
Erik Nillsson, President, Insilicos Presentation Slides

Thank you to Microsoft for their generous sponsorship of this event. 

8/30/10 Thea Chard of Xconomy reports on the WBBA HIT program:  Electronic Data Sharing, Cloud-Computing, and Collaboration: The WBBA Talks on the Future of Health IT

Return to top

Secrets of NIH Small Business Grant Applications
Seattle and Spokane

When the going (funding) gets tough, the tough go shopping (for grants and contracts). As NIH success rates enter single digits and venture capital funding diminishes, academic investigators and small companies collaborate to obtain federal small business funds (SBIR and STTR). WBBA was pleased to host Gregory Milman, Ph.D., Director of the Office for Innovation and Special Programs in the National Institute of Allergy and Infectious Diseases (NIAID) as he led a workshop on August 3, at Zymogenetics, in Seattle and on August 4, at SIRTI, in Spokane. 

Dr. Milman discussed, among other topics, real NIH funding limits, success rates for NIH applications, how to write for NIH review criteria, and how academic investigators can tap into NIH funds.  In Seattle, he led a panel of local NIH grant recipients in a discussion that highlighted the panelists’ strategies for producing winning proposals.

Review Dr. Milman’s presentation slides.

Return to top

Summer Social 2010

Fun in the sun!  The Shilshole Bay Beach Club and the best weather of the year combined with fantastic and fun sponsor displays and over 250 life science friends to make the WBBA's 12th Annual Summer Social the best ever! 

Thank you to our generous and creative sponsors:
  Airgas, BarclayDean Environments, BNBuilders, Employer Resources NW, Fenwick & West, Graphica, Lab Research Inc., Lilly USA, LLC, MedIntellibase, Praxair, Puget Sound Bank, Seed IP Law Group PLLC, and Wells Fargo Insurance Services.

The music of the steel drum band set the island mood and we have pictures to prove it!  Don't miss the fun next year!

Return to top

Pub Night- Bellevue

On June 3rd, Pub Night festivities moved to Bellevue where 45 life science colleagues got together for networking and cocktails at the Bellevue Grill.  If you have a venue idea for a WBBA Pub Night, please contact Darcy Jacobson.  Don't miss the fun at the October 7 Pub Night.  Mark your calendar!

Return to top

Domesticating Global Health: "Domestic Companies with Global Health Impact"

The third installment of the Domesticating Global Health series: "Domestic Companies with Global Health Impact" was held on May 25 at Seattle Biomedical Research Institute (SBRI). 

The distingushed  panel of experts, moderated by Lisa Cohen,  MA, Director, Washington Global Health Alliance included:
Anne Bugge,Vice President, Global Public Health, Sonosite
Karen Hedine, President & CEO, Micronics, Inc.
John Kaestle, President & CEO, HaloSource

Discussion centered on ways to better position Washington state as a Global Health Epi-Center and leverage the global health community.  With the support of Global Health Nexus Seattle, WBBA is pleased to offer this event via webcast.  View it online now!

Thank you to the event sponsors: BNBuilders, City of Seattle Office of Economic Development, Washington Global Health Alliance. and our host Seattle BioMed.

Don't miss part four of the series on November 10: "Closing the Gap."

Return to top

Business with Asia

This program from WBBA's Business Development Series focused on Washington state's continued expansion of our Asian trade relationship and  the budding partnership opportunities for life science companies in the Asian market.  This event was designed to provide access to and engage prospective relations for Washington organizations who wish to partner and access capital from China, Japan, Korea and Taiwan.  Case studies of companies that have successfully completed alliances in the East were presented.

A panel of experts was led by Moderator Susan Wang, PhD, Strategic Director - Asia and Chief Representative / Shanghai Rep Office for Ricerca Biosciences (formally MDS Pharma).

Panelists Included:
David Fanning, President & CEO, Theraclone Sciences
Ryo Kubota, M.D., Ph.D. Chairman, President & CEO,  Acucela
Biaoyang Lin, Ph.D., Research Scientist, Swedish Neuroscience Institute & Professor and Director, Systems Biology, Zhejiang-California International Nanosystems Institute (ZCNI), Hangzhou, China
Daniel Liao, Director General, Taipei Economic and Cultural Office, Seattle
Takashi Nagao, President, Mitsubishi Tanabe Pharma America, Inc.


Return to top

Emerging Biomass Innovation

In a program designed to highlight the state’s most innovative discoveries, technologies and innovation that Washington has to offer, four panelists discussed the opportunities and challenges of biomass development as part of the WBBA’s Breakfast for Success Life Science Innovation Series.

Alternative fuels produced from algae, seaweed and other natural sources may result in substantial benefit to the Northwest, including treatment of industrial wastewater, increased crop production and growing synergy between the life sciences and information technology.

The trick is to find and fund commercialization strategies that recognize customer-driven needs and a defined route to the market place. 

The panelists were Margaret McCormick, general manager, bio-based materials for Targeted Growth; Rick LeFaivre of the University of Washington Center for Commercialization;  Rose Ann Cattolico, a UW research biologist; and Linda Beltz, director of Technology Partnerships/Open Innovation at Weyerhaeuser. The discussion was moderated by John Gardner, vice president of Washington State University’s Office of Economic Development and Extension and a member of the Washington Clean Energy Leadership Council, and helping to lead the charge for alternative energy technologies in Washington state.  Read the event summary.

Return to top 

Pub Night- No Foolin'

The Pike Place Brewery was the place to be on April Fool's Day.  Sixty-eight industry colleagues came together to network and enjoy a tasty pint!  Register today for the next Pub Night- June 3 at the Bellevue Grille at the Bellevue Sheraton!

Return to top

2010 Life Science Innovation Northwest

Hundreds from the life sciences community from 15 states, Washington, D.C., and seven countries -- Australia, Canada, China, Denmark, Germany, Japan and the United Kingdom -- attended Life Science Innovation Northwest held March 16 and 17 in Seattle.

“We’re extremely pleased that so many outstanding professionals attended this year’s event,” said Chris Rivera, President, Washington Biotechnology & Biomedical Association. “It demonstrates continued growth in the life sciences industry and a growing global understanding that Washington state is taking its place among top leaders in innovation."

Attendees were treated to two days of panel discussions, a state-of-the-industry report by G. Steven Burrill, CEO of Burrill & Company, the keynote address by Rajiv Shah, administrator of the U.S. Agency for International Development, and presentations by life science companies and leading research and global health organizations.

Burrill & Company joined WBBA to co-sponsor this year's event.

Learn more about the 2010 event from a Special Edition of The Life Science Innovator newsletter or the 2010 LSINW webpages.

Return to top

Academia to Industry

Led by moderator Ulrich Mueller, Ph.D., Vice President, Fred Hutchinson Cancer Research Center, panelists explored the differences between academia and industry. The interactive program addressed questions from the diverse audience on topics such as career opportunities and how to prepare for them and how to get your foot in the door.  The team of experienced executives described what a biotech job looks like and how to evaluate if you’re ready for the transition.

Thank you to our panelists:
Michael Gallatin, Ph.D., President and Co-founder, Calistoga Pharmaceuticals, Jonathan Drachman, M.D., Vice President, Translational Medicine at Seattle Genetics and Kenneth Ferguson, Ph.D., President and CEO, Imvaxyn, Inc.

Our generous and gracious host was Fred Hutchinson Cancer Research Center.

Return to top

Domesticating Global Health: "Doctor Ready"

The event was held on February 10 at Seattle Biomedical Research Institute (SBRI).

The distingushed  panel of experts included:
Bernhard H Weigl, PhD, MSc, Group Leader, Diagnostic Development Teams, PATH- View Presentation Slides
Craig Rubens, MD, PhD - Children’s Hospital of Seattle; Executive Director, GAPPS
Curt Malloy, JD, PRH, President, Infectious Disease Research Institute (IDRI)- View Presentation Slides
Barry Lutz, PhD - University of Washington, Department of Bioengineering- View Presentation Slides
Lisa Cohen, Washington Global Health Alliance – Moderator

Discussion centered on Washington state as a nexus for global health research and development. Low-cost, effective devices and diagnostics designed here are transforming healthcare worldwide, especially in developing countries who are most in need of help. In the second of the four-part series; “Domesticating Global Health”, our expert panel highlighted several innovative technologies that are being developed for the Global Health community, many of which will also have domestic applications here at home. 

Thank you to the event sponsors: BNBuilders, City of Seattle Office of Economic Development, Washington Global Health Alliance. and our host SBRI.

Don't miss part three of the series on May 26: "Domestic Companies with Global Health Impact."

Return to top

Bio on the Vine

WBBA kicked the year off with Bio on the Vine (aka "Pub Night") on January 19 at Fortunato's Wine Bar in Woodinville.  Distinguished speaker Thomas Henick-Kling, PhD.  gave a riveting presentation entitled "Microbes and Wine Quality - Are microorganisms the tool to let wines express their regional identity (terroir) or are they the foe?"   to a packed house.

Dr. Henick-Kling is the Director of the Wine Science Program and Professor of Enology at Washington State University.  Henick-Kling is a wine microbiologist and has commercial and experimental winemaking experience and extensive knowledge of wines from Europe, USA, Australia and New Zealand. He is active in several national and international professional societies.  He is a wine judge and a reviewer for several scientific journals.

Thank you to our host Fortunato's Wine Bar.

Return to top

2009 Annual Meeting

Washington's life sciences community joined WBBA for our 2009 Annual Meeting on November 6 in Seattle.
 
The program featured Dr. Elias Zerhouni, former Director of the National Institute of Health, presenting "Translational Research and Global Health: the Impact on Washington State."   View Dr. Zerhouni's presentation slides.  

We Work for Health provided a report on its Life Science Economic Impact Study and the WBBA followed with a report on our progress in 2009, our current challenges and the coming opportunities in life sciences locally, nationally and globally. 

WBBA thanks our sponsors that helped us make this event a success!

Return to top

2010 Event Archives

Dec. 7: Pub Night
Nov. 18 The Pathway to Biosimilars?
Nov. 3: Innovative Investing in Global Health: What’s in it for your organization? Domesticating Global Health Part 4
Oct. 22: Governor's Life Sciences Summit and Annual Meeting 2010
Sep 14: Planning for Your Drug Development Success: From the Bench to the Clinic
Sep 13: WBBA's Sixth Annual Golf Invitational
Aug. 25: Healthcare IT
Aug. 3 & 4: Secrets of NIH Small Business Grant Applications-Seattle and Spokane
July 15: Summer Social
June 3: Pub Night- Bellevue
May 25: Domesticating Global Health: "Domestic Companies with Global Health Impact"
May 20: Business with Asia
Apr. 27: Emerging Biomass Innovation
Apr.1: Pub Night
Mar. 16-17: Life Science Innovation Northwest
Feb 24: Academia to Industry
Feb. 10: Domesticating Global Health: "Doctor Ready"
Jan. 19: Bio on the Vine

2009

Nov. 6: Annual Meeting

 

View upcoming events


© 2012 Washington Biotechnology & Biomedical Association

        
Powered by YourMembership.com